Primavera Nueva Inc. Issues Voluntary Recall of Select 4-Count Tamales Because of Possible Health Risk- Revised to Include Roasted Pumpkin & White Cheddar, a Seasonal Item

In accordance with section 505A(e)(1) of the Act, as amended by FDAAA (Pub. L. No. 110-85), the following list identifies those approved drugs for which a pediatric exclusivity determination was made, on or after September 27, 2007.

The FDA recommends that consumers avoid 7-OH products, including foods, dietary supplements and those claiming to treat an ailment or disorder. 7-OH is not approved as a drug by the FDA.

FDA’s Center for Drug Evaluation and Research (CDER) recently accepted a new submission into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. This submission is the first artificial intelligence-based and digital health technology-based project and the first pro

The U.S. Food and Drug Administration (FDA) approved Palsonify (paltusotine) tablets to treat adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.

Medline is recalling certain Convenience Kits due to being labeled as sterile but not having gone through the sterilization process

Drug Trials Snapshots: HERNEXEOS